Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
University of Montreal
Montreal, CanadáPublikationen in Zusammenarbeit mit Forschern von University of Montreal (14)
2024
2023
2020
-
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1
-
The Smc5/6 Core Complex Is a Structure-Specific DNA Binding and Compacting Machine
Molecular Cell, Vol. 80, Núm. 6, pp. 1025-1038.e5
2019
-
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
The Lancet Haematology, Vol. 6, Núm. 9, pp. e448-e458
2018
-
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
The Lancet, Vol. 391, Núm. 10137, pp. 2325-2334
2016
-
Centrosome-Dependent Bypass of the DNA Damage Checkpoint by the Polo Kinase Cdc5
Cell Reports, Vol. 14, Núm. 6, pp. 1422-1434
-
Checkpoint adaptation: Keeping Cdc5 in the T-loop
Cell Cycle
2014
-
Consensus guidelines for the detection of immunogenic cell death
OncoImmunology, Vol. 3, Núm. 9
-
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: A multicentre, randomised, double-blind phase 3 trial
The Lancet Oncology, Vol. 15, Núm. 11, pp. 1195-1206
-
The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: A meta-analysis in patients with cancer
Pharmacogenomics Journal, Vol. 14, Núm. 2, pp. 115-119
2012
-
Restricciones físicas en UCI: su utilización y percepción de pacientes y familiares
Enfermeria Intensiva, Vol. 23, Núm. 2, pp. 77-86
2010
-
La calidad asistencial en cuidados intensivos evaluada por los pacientes mediante la escala SERVQUAL
Enfermeria Intensiva, Vol. 21, Núm. 1, pp. 3-10